• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    Maryland Register

    Issue Date:  June 7, 2019

    Volume 46 • Issue 12 • Page 553

    Title 10 


    Notice of Proposed Action


    The Secretary of Health proposes to amend:

    (1) Regulation .01 under COMAR 10.09.62 Maryland Medicaid Managed Care Program: Definitions; and

    (2) Regulation .24 under COMAR 10.09.67 Maryland Medicaid Managed Care Program: Benefits.

    Statement of Purpose

    The purpose of this action is to implement the National Diabetes Prevention Program (National DPP), an evidence-based diabetes prevention program established by the Centers for Disease Control and Prevention (CDC), beginning July 2019. Additionally, this proposal corrects an error in the definition of “long-term care facility” by explicitly including special pediatric hospitals.

    Comparison to Federal Standards

    There is no corresponding federal standard to this proposed action.

    Estimate of Economic Impact

    I. Summary of Economic Impact. Based on preliminary analysis, the total estimated cost of the program over the waiver period (through December 2021) is approximately $15.2 million total funds (61 percent federal funds, 39 percent general funds). Given a start date of July 1, 2019, the estimate cost for FY 20 is approximately $6 million total funds (61 percent federal funds, 39 percent general funds).



    Revenue (R+/R-)


    II. Types of Economic Impact.






    A. On issuing agency:



    B. On other State agencies:


    C. On local governments:




    Benefit (+)
    Cost (-)




    D. On regulated industries or trade groups:



    E. On other industries or trade groups:


    F. Direct and indirect effects on public:


    III. Assumptions. (Identified by Impact Letter and Number from Section II.)

    A. This amount assumes the Centers for Medicare and Medicaid Services (CMS) will approve the waiver the Department applied for to implement the National DPP program. Subject to the approval of CMS, the program will go into effect July 1, 2019 and continue through the waiver period until December 2021. The program will serve individuals between the ages of 18 and 64 who are enrolled in HealthChoice MCOs and meet program eligibility criteria indicating presence of prediabetes or at risk for type 2 diabetes. The average cost per person is $500 per year. The Department estimates 11,896 adults will be eligible for the initial program year and anticipates 3 percent population inflation each year.

    D. This estimate assumes 100 percent of the total cost will be used to cover service costs paid to National DPP providers.

    Economic Impact on Small Businesses

    The proposed action has minimal or no economic impact on small businesses.

    Impact on Individuals with Disabilities

    The proposed action has no impact on individuals with disabilities.

    Opportunity for Public Comment

    Comments may be sent to Jake Whitaker, Acting Director, Office of Regulation and Policy Coordination, Maryland Department of Health, 201 West Preston Street, Room 512, Baltimore, MD 21201, or call 410-767-6499 (TTY 800-735-2258), or email to mdh.regs@maryland.gov, or fax to 410-767-6483. Comments will be accepted through July 8, 2019. A public hearing has not been scheduled.


    10.09.62 Maryland Medicaid Managed Care Program: Definitions

    Authority: Health-General Article, §§15-101 and 15-103(b), Annotated Code of Maryland

    .01 Definitions.

    A. (text unchanged)

    B. Terms Defined.

    (1)—(98) (text unchanged)

    (99) “Long-term care facility” means a chronic hospital, a chronic rehabilitation hospital, [or] a nursing facility, or a special pediatric hospital.

    (100)—(120) (text unchanged)

    (120-1) “National Diabetes Prevention Program” means an evidence-based diabetes prevention program established by the Centers for Disease Control and Prevention.

    (121)—(182) (text unchanged)


    10.09.67 Maryland Medicaid Managed Care Program: Benefits

    Authority: Health-General Article, Title 15, Subtitle 1, Annotated Code of Maryland

    .24 Benefits — Diabetes Prevention and Care Services.

    A. An MCO shall provide to its qualifying enrollees medically necessary diabetes prevention and care services as specified in this regulation.

    B. National Diabetes Prevention Program.

    (1) In addition to the services included in its usual benefits package, an MCO shall make available to its enrollees who meet the Centers for Disease Control and Prevention (CDC) eligibility criteria defined in §B(2) of this regulation the National Diabetes Prevention Program through a CDC-recognized lifestyle change organization.

    (2) To be eligible for participation in the National Diabetes Prevention Program, a HealthChoice enrollee:

    (a) Shall be 18 through 64 years old;

    (b) Shall be overweight or obese;

    (c) Shall have an elevated blood glucose level or a history of gestational diabetes mellitus;

    (d) May not have a previous diagnosis of type 1 or type 2 diabetes prior to enrollment; and

    (e) May not be currently pregnant.

    [B.] C. (text unchanged)

    Secretary of Health